Clinical Trials
90 trialsTrial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors
Fox Chase Cancer Center
EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
Case Comprehensive Cancer Center
PRO-NEM1
Centre Hospitalier Universitaire Dijon
Tumor HI
Rezolute
Using Novel Imaging to More Safely Treat Neuroendocrine Tumors
University of Wisconsin, Madison
ELEGANCE
Nantes University Hospital
LEVEL
Grupo Espanol de Tumores Neuroendocrinos
68Ga-HA-DOTATATE Imaging of Suspected Somatostatin Receptor Positive Tumors
University of Alberta
iCaRe2
University of Nebraska
SVV-001 With Nivolumab and Ipilimumab in Patients With Poorly Differentiated Neuroendocrine Carcinomas (NEC) or Well-Differentiated High-Grade Neuroendocrine Tumors (NET)
University of Miami
ANTARES
Instituto do Cancer do Estado de São Paulo
LUPARPED
Fundación de investigación HM
Cabozantinib and Lanreotide as Treatment for Gastroenteropancreatic Neuroendocrine Tumors
National Health Research Institutes, Taiwan
PRRT
Methodist Health System
SUR-CAN
Centre Oscar Lambret
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Lenvatinib Plus Pembrolizumab in Well Differentiated G3 Neuroendocrine Tumors
University of California, San Francisco
Management of Pancreatic Cystic Lesions Using Artificial Intelligence Based on EUS and Multimodal Data
Huazhong University of Science and Technology
Combination External Radiation and PRRT for Large GI Neuroendocrine Tumors.
Emory University
LINEAR
European Institute of Oncology
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Cedars-Sinai Medical Center
The Use of Guarana to Treat Fatigue in Patients With Neuroendocrine Tumors and Gynecologic Cancers (Guarana Fatigue)
University of Utah
18F-DOPA II - PET Imaging Optimization
University of Alberta
BCB RIV
Institut du Cancer de Montpellier - Val d'Aurelle
ReLUTH
Institut du Cancer de Montpellier - Val d'Aurelle
F-Tryptophan PET/CT in Human Cancers
Barbara Ann Karmanos Cancer Institute
Surufatinib Combined With Chemo Versus Surufatinib in the Treatment of Pulmonary Neuroendocrine Tumors
Shanghai Chest Hospital
FARINET
IRCCS San Raffaele
Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases
Mayo Clinic
DENUTNE
University Hospital, Strasbourg, France
ZSPAC-17
Shanghai Zhongshan Hospital
Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors
Vanderbilt-Ingram Cancer Center
Zanzalintinib Maintenance in Patients With High Grade Neuroendocrine Neoplasms (HG-NENs)
Washington University School of Medicine
CapTemY90
Abramson Cancer Center at Penn Medicine
LANTana
Imperial College London
LUTIBI
Institut Claudius Regaud
IMMUNORARE5
Hospices Civils de Lyon
An Investigational Scan ([68Ga] Ga-FAPI-04 PET/CT) for the Imaging of Patients With High-Grade Neuroendocrine Cancer
University of Michigan Rogel Cancer Center
OPERANDI-NET
Assistance Publique - Hôpitaux de Paris
START-NET
Lund University Hospital
Study of PRRT in Metastatic, World Health Organization (WHO) Grade 1 or 2, SSTR Positive, GEP-NET Who Are Candidates for Cytoreductive Surgery
Stanford University
RIALTO
Grupo Espanol de Tumores Neuroendocrinos
Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors
Barbara Ann Karmanos Cancer Institute
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
Jonsson Comprehensive Cancer Center
LUTARTERIAL
University Hospital, Bordeaux
LUMOD-ID
University of Iowa
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers
University of Pittsburgh
NIP IT!
University Health Network, Toronto
A Phase I Study to Assess the Safety and Efficacy of [225Ac]Ac-DOTATATE in Patients With SSTR+ GEP-Nens
Peking University Cancer Hospital & Institute
AURA-RIV-TNE
Hospices Civils de Lyon